Restorative effect of repetitive administration of Shaoyao-Gancao-tang on bioavailability of paeoniflorin reduced by antibacterial synthetic drugs treatment in rats.

Paeoniflorin (PF) is an active glucoside in Shaoyao (peony root), and is transformed into an antispasmodic metabolite, paeonimetabolin-I (PM-I), by intestinal bacteria in the gut after oral administration of Shaoyao or Shaoyao-Gancao-tang (SGT, Shakuyaku-Kanzo-To in Japanese). SGT is a pain-relieving traditional Chinese formulation (Kampo-medicine in Japanese) and is often used together with antibacterial synthetic drugs, such as amoxicillin and metronidazole (AMPC-MET), in peptic ulcer therapy. Since the bioavailability of PF in SGT has been reported to be significantly reduced by co-administered antibacterial drugs, we investigated how to minimize this reducing effect of antibacterial treatment in the present study. We found that repetitive administration of SGT starting 24 h after AMPC-MET treatment rapidly restored the plasma PM-I concentration from SGT reduced by AMPC-MET, due to its restorative effect on the decreased PF-metabolizing activity of intestinal bacteria in rat feces. The present findings suggest that it may be clinically useful to administer SGT repetitively, starting 1 or 2 d after treatment with a mixture of AMPC-MET during their combination therapy, to accelerate the recovery of the reduced bioavailability of PF in SGT. Similar administration regimens may also be useful in other combination therapies involving traditional Chinese formulations and antibacterial synthetic drugs to ensure the efficacy of the bioactive glycosides in the formulations.

[1]  Junxian He,et al.  Influence of co‐administered antibiotics on the pharmacokinetic fate in rats of paeoniflorin and its active metabolite paeonimetabolin‐I from Shaoyao‐Gancao‐tang , 2003, The Journal of pharmacy and pharmacology.

[2]  M. Ishihara,et al.  [Combination use of kampo-medicines and drugs affecting intestinal bacterial flora]. , 2002, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[3]  Junxian He,et al.  Development of a simple HPLC method for determination of paeoniflorin-metabolizing activity of intestinal bacteria in rat feces. , 2002, Chemical & pharmaceutical bulletin.

[4]  Ling-Ling Yang,et al.  Pharmacokinetic interactions between carbamazepine and the traditional Chinese medicine Paeoniae Radix. , 2002, Biological & pharmaceutical bulletin.

[5]  Junxian He,et al.  The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang. , 2001, Biological & pharmaceutical bulletin.

[6]  M. Meselhy,et al.  Anticonvulsant activity of paeonimetabolin-I adducts obtained by incubation of paeoniflorin and thiol compounds with Lactobacillus brevis. , 1999, Biological & pharmaceutical bulletin.

[7]  N. Nishimura,et al.  Effects of Sho‐saiko‐to on the Pharmacokinetics and Pharmacodynamics of Tolbutamide in Rats , 1998, The Journal of pharmacy and pharmacology.

[8]  W. B. Currie,et al.  Dynamics of maturation-promoting factor and its constituent proteins during in vitro maturation of bovine oocytes. , 1997, Biology of reproduction.

[9]  K. Kobashi,et al.  Metabolism of Drugs by Intestinal Bacteria , 1992 .

[10]  T. Tsukihara,et al.  Metabolism of paeoniflorin and related compounds by human intestinal bacteria. II. Structures of 7S- and 7R-paeonimetabolines I and II formed by Bacteroides fragilis and Lactobacillus brevis. , 1987, Chemical & pharmaceutical bulletin.

[11]  Y. Benno,et al.  Development of Intestinal Microflora in Humans and Animals , 1986 .

[12]  V. Rotimi,et al.  The development of the bacterial flora in normal neonates. , 1981, Journal of medical microbiology.

[13]  J. Rowe The sterols of pine bark , 1965 .